SIHUAN PHARMACEUTICAL HOLDINGS GROUP LTD.

Press Releases Sihuan Pharmaceutical Holdings Group Ltd.

Equities

460 BMG8162K1137

Market Closed - Hong Kong S.E. Other stock markets 04:08:05 2024-05-31 am EDT			5-day change	1st Jan Change
0.54 ^HKD	-.--%		-5.26%	-16.92%

May. 27	Sihuan Pharmaceutical, Unit Withdraw Latter's Stock Exchange Bid, Shares Down by Over 3%	MT
May. 02	Sihuan Pharmaceutical Unit's Lung Cancer Drug NDA Accepted by NMPA, Stocks Shoot Over 10%	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Sihuan Pharmaceutical Was Selected As One Of The First Echelon Of Enterprises In The list of China's Top 100 Pharmaceutical Innovative Enterprises in 2023	23-10-13	AQ
Xuanzhu Biopharm, a subsidiary of Sihuan Pharmaceutical, Its Innovative Drug Anaprozole Sodium Enteric-coated Tablets Obtains Drug Registration Approval From NMPA	23-06-27	AQ
Xuanzhu Biopharm, a subsidiary of Sihuan Pharmaceutical, progresses at full speed in innovative research and development Presents major research results of birociclib, the start product, at the international stage in ASCO	23-06-08	AQ
Sihuan Pharmaceutical(0460.HK): Respond to the special directives to combat illegal medical aesthetics services, Advocate 'Positive Energy' of China's Medical Aesthetics Industry	21-08-11	AQ
Sihuan Pharmaceutical : VOLUNTARY ANNOUNCEMENT - INSULIN ASPART 30 INJECTION DEVELOPED BY SIHUAN PHARMACEUTICAL ACHIEVED EQUIVALENT CLINICAL RESULTS IN EFFICACY AND SAFETY STUDY AS ORIGINATOR DRUG	21-07-30	PU
Sihuan Pharmaceutical : VOLUNTARY ANNOUNCEMENT-ENTERING INTO STRATEGIC COOPERATION AGREEMENT BETWEEN JILIN HUISHENG BIOPHARMACEUTICAL AND PORTON PHARMA	21-04-28	PU
Sihuan Pharmaceutical : VOLUNTARY ANNOUNCEMENT - SHARE REPURCHASE	21-04-09	PU
Sihuan Pharmaceutical : VOLUNTARY ANNOUNCEMENT-SIHUAN PHARMACEUTICAL OBTAINED DRUG REGISTRATION APPROVAL IN RELATION TO AMBROXOL HYDROCHLORIDE INJECTION	21-04-01	PU
Sihuan Pharmaceutical : VOLUNTARY ANNOUNCEMENT PROPOSED SHARE REPURCHASE UNDER THE GENERAL MANDATE	21-03-28	PU
Sihuan Pharmaceutical : VOLUNTARY ANNOUNCEMENT SIHUAN PHARMACEUTICAL OBTAINED DRUG REGISTRATION APPROVAL IN RELATION TO RIVAROXABAN TABLETS	21-03-25	PU
Sihuan Pharmaceutical : ANNOUCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2020	21-03-23	PU
Sihuan Pharmaceutical : VOLUNTARY ANNOUNCEMENT THE GROUP'S LIRAGLUTIDE HAS COMPLETED PHASE I CLINICAL STUDY FOR INDICATION OF WEIGHT LOSS	21-02-25	PU
Sihuan Pharmaceutical : Launched an Equity Incentive Plan to Inject New Impetus for the Company's Growth	20-08-27	AQ
Sihuan Pharmaceutical : Announces 2020 Interim Results	20-08-25	AQ
Sihuan Pharmaceutical : CLARIFICATION ANNOUNCEMENT	20-08-24	PU
Sihuan Pharmaceutical : VOLUNTARY ANNOUNCEMENT OFFICIAL RELEASE OF THE RESULT OF LARGE-SCALE CLINICAL TRIALS AFTER THE LAUNCH OF CINEPAZIDE MALEATE INJECTION THE DRUG TAKES STROKE TREATMENT INTO A NEW ERA WITH ITS VERIFIED EFFICACY	20-08-21	PU
Sihuan Pharmaceutical : VOLUNTARY ANNOUNCEMENT - CAPITAL INJECTION BY NEW INVESTORS INTO BEIJING RUIYE DRUGS MANUFACTURE CO., LTD. (AN ASSOCIATE OF SIHUAN PHARMACEUTICAL) TO ACCELERATE CAPACITY EXPANSION	20-08-19	PU
Sihuan Pharmaceutical : NOTICE OF BOARD MEETING	20-08-13	PU
Sihuan Pharmaceutical : PROFIT WARNING MAINLY ATTRIBUTABLE TO RECOGNITION OF IMPAIRMENT LOSSES	20-03-13	PU
Sihuan Pharmaceutical : VOLUNTARY ANNOUNCEMENT - ACQUISITION OF ALL INTERESTS AND INTELLECTUAL PROPERTY RIGHTS OF PLAZOMICIN, A NEW GENERATION OF AMINOGLYCOSIDE ANTIBIOTICS IN THE GREATER CHINA REGION	20-02-20	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Sihuan Pharmaceutical Holdings Group Ltd.

Equities

460

BMG8162K1137

Press Releases

Filters